COVID-19 Quantitative Antibody Titers & Booster Vaccinations

Clinical trial NCT05104359 · COMPLETED

Trial details

NCT number: NCT05104359
Sponsor: Epividian
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 COVID-19 Vaccines Immunogenicity, Vaccine

Start date: 2020-12-11
Primary completion: 2022-04-30
Enrollment: 825

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.